Neuland Laboratories Limited announced the appointment of Dr. Sharadsrikar V.Kotturi has been appointed as Chief Scientific Officer, effective from November 22, 2023. Dr. Kotturi holds a PhD in chemistry from Oklahoma State University (USA) and MSc (Tech) in Chemical Technology from UDCT, Bombay. Sharad brings over 20 years of experience in R&D across organizations such as Advinus Therapeutics Limited, GVK Biosciences Private Limited, Urikot Research, Durham, RTI International (USA), among others.

His last role was with Piramal Pharma Limited, Mumbai where he was designated as Senior Vice President Operations and was responsible for the P&L of Discovery Services and Peptides Business. His area of expertise includes Discovery and development, Analytical R&D, conceptualization and development of sustainable chemistries for tech transfers of Agrochemicals (AI, AI intermediates), Electronic chemicals (OLED monomers), Flavors, Pharma (NCEs, Gx APIs, API intermediates, IND packages, Integrated Drug Discovery Programs, Peptide APIs, Perfumery, and Vitamins, Circular chemistries, business strategy, Scientific & Operation Excellence and Lean Labs.